3QFY16 standalone EBITDA disappoints: HATH's 3QFY16 standalone EBITDA grew 46% QoQ to INR498m (vs. est: INR646m). EBITDA (ex-activation) declined 7% QoQ to INR275m (vs. est: INR326m). Standalone revenue grew 10% QoQ to...